Ikarian Capital’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-18,647
| Closed | -$133K | – | 118 |
|
|
2023
Q3 | $133K | Sell |
18,647
-131,353
| -88% | -$935K | 0.02% | 69 |
|
|
2023
Q2 | $1.53M | Buy |
+150,000
| New | +$1.53M | 0.24% | 40 |
|
|
2022
Q4 | – | Sell |
-479,383
| Closed | -$3.13M | – | 79 |
|
|
2022
Q3 | $3.13M | Sell |
479,383
-404,625
| -46% | -$2.64M | 0.62% | 25 |
|
|
2022
Q2 | $4.26M | Sell |
884,008
-86,090
| -9% | -$415K | 0.78% | 19 |
|
|
2022
Q1 | $5.51M | Buy |
970,098
+68,736
| +8% | +$390K | 0.72% | 21 |
|
|
2021
Q4 | $4.53M | Hold |
901,362
| – | – | 0.67% | 24 |
|
|
2021
Q3 | $5.99M | Sell |
901,362
-193,662
| -18% | -$1.29M | 0.42% | 18 |
|
|
2021
Q2 | $6.69M | Sell |
1,095,024
-213,675
| -16% | -$1.31M | 0.54% | 22 |
|
|
2021
Q1 | $8.7M | Sell |
1,308,699
-157,448
| -11% | -$1.05M | 0.29% | 21 |
|
|
2020
Q4 | $7.76M | Sell |
1,466,147
-15,000
| -1% | -$79.4K | 0.34% | 21 |
|
|
2020
Q3 | $11M | Buy |
1,481,147
+12,500
| +0.9% | +$93.1K | 0.8% | 8 |
|
|
2020
Q2 | $10.8M | Buy |
1,468,647
+395,000
| +37% | +$2.91M | 0.86% | 9 |
|
|
2020
Q1 | $7.95M | Buy |
+1,073,647
| New | +$7.95M | 0.6% | 10 |
|